Collegium Pharmaceutical Inc (COLL) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $22.80 (+1.88%), Market cap $1.10B, P/E ratio 16.50, 52-week low–high $28.82 ~ $49.84.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formu
Financial statements, price targets, institutional (13F) holdings and related news for Collegium Pharmaceutical Inc are updated in real time on BlackAll Trade.
Collegium Pharmaceutical Inc trades at $22.80 (+1.88%). Real-time quotes and charts are available on BlackAll Trade.
Collegium Pharmaceutical Inc has a market cap of about $1.10B. Its P/E ratio is 16.50.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a cen